Literature DB >> 25409679

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.

Huan Yan1, Guocai Zhong2, Guangwei Xu2, Wenhui He2, Zhiyi Jing2, Zhenchao Gao1, Yi Huang2, Yonghe Qi2, Bo Peng2, Haimin Wang2, Liran Fu2, Mei Song2, Pan Chen2, Wenqing Gao2, Bijie Ren2, Yinyan Sun2, Tao Cai2, Xiaofeng Feng2, Jianhua Sui2, Wenhui Li2.   

Abstract

Human hepatitis B virus (HBV) infection and HBV-related diseases remain a major public health problem. Individuals coinfected with its satellite hepatitis D virus (HDV) have more severe disease. Cellular entry of both viruses is mediated by HBV envelope proteins. The pre-S1 domain of the large envelope protein is a key determinant for receptor(s) binding. However, the identity of the receptor(s) is unknown. Here, by using near zero distance photo-cross-linking and tandem affinity purification, we revealed that the receptor-binding region of pre-S1 specifically interacts with sodium taurocholate cotransporting polypeptide (NTCP), a multiple transmembrane transporter predominantly expressed in the liver. Silencing NTCP inhibited HBV and HDV infection, while exogenous NTCP expression rendered nonsusceptible hepatocarcinoma cells susceptible to these viral infections. Moreover, replacing amino acids 157-165 of nonfunctional monkey NTCP with the human counterpart conferred its ability in supporting both viral infections. Our results demonstrate that NTCP is a functional receptor for HBV and HDV.

Entities:  

Keywords:  Sodium taurocholate cotransporting polypeptide; biochemistry; hepatitis B virus; hepatitis D virus; infectious disease; liver; microbiology; receptor; virus infection; viruses

Mesh:

Substances:

Year:  2012        PMID: 25409679     DOI: 10.7554/eLife.00049

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  36 in total

Review 1.  Present and future therapies of hepatitis B: From discovery to cure.

Authors:  T Jake Liang; Timothy M Block; Brian J McMahon; Marc G Ghany; Stephan Urban; Ju-Tao Guo; Stephen Locarnini; Fabien Zoulim; Kyong-Mi Chang; Anna S Lok
Journal:  Hepatology       Date:  2015-10-27       Impact factor: 17.425

Review 2.  HBV/HDV Coinfection: A Challenge for Therapeutics.

Authors:  Christopher Koh; Ben L Da; Jeffrey S Glenn
Journal:  Clin Liver Dis       Date:  2019-05-24       Impact factor: 6.126

3.  Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle.

Authors:  Hironori Nishitsuji; Hiromi Yamamoto; Ritsuko Shiina; Keisuke Harada; Saneyuki Ujino; Kunitada Shimotohno
Journal:  J Vis Exp       Date:  2017-02-01       Impact factor: 1.355

4.  T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.

Authors:  Bingqian Qu; Yi Ni; Florian A Lempp; Florian W R Vondran; Stephan Urban
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

5.  An Effective Antiviral Approach Targeting Hepatitis B Virus with NJK14047, a Novel and Selective Biphenyl Amide p38 Mitogen-Activated Protein Kinase Inhibitor.

Authors:  So-Young Kim; Hong Kim; Sang-Won Kim; Na-Rae Lee; Chae-Min Yi; Jinyuk Heo; Bum-Joon Kim; Nam-Jung Kim; Kyung-Soo Inn
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

Review 6.  Current and future directions for treating hepatitis B virus infection.

Authors:  Akinobu Tawada; Tatsuo Kanda; Osamu Yokosuka
Journal:  World J Hepatol       Date:  2015-06-18

Review 7.  Liver and Kidney on Chips: Microphysiological Models to Understand Transporter Function.

Authors:  S Y Chang; E J Weber; Kp Van Ness; D L Eaton; E J Kelly
Journal:  Clin Pharmacol Ther       Date:  2016-08-27       Impact factor: 6.875

8.  Regulation of plasma membrane localization of the Na+-taurocholate cotransporting polypeptide (Ntcp) by hyperosmolarity and tauroursodeoxycholate.

Authors:  Annika Sommerfeld; Patrick G K Mayer; Miriam Cantore; Dieter Häussinger
Journal:  J Biol Chem       Date:  2015-08-25       Impact factor: 5.157

9.  Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.

Authors:  Thomas Lahlali; Jan Martin Berke; Karen Vergauwen; Adrien Foca; Koen Vandyck; Frederik Pauwels; Fabien Zoulim; David Durantel
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

10.  Current and Future Management of Chronic Hepatitis D.

Authors:  Patrizia Farci; Grazia Anna Niro
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.